Medco's Fringe Benefits

It should be a day of celebration for Medco HealthSolutions (NYSE: MHS  ) . Late Monday afternoon, the Department of Justice said the pharmacy-benefits manager had reached a settlement in a long-standing federal inquiry. What's more, investors don't have to worry that the $155 million settlement will dampen earnings, because Medco took a $163 million charge in the first quarter to account for the agreement, which was in the works at that time.

However, the market hasn't been exactly jubilant since the settlement: Shares are down slightly. A likely reason is that two new developments are making shareholders uneasy. While investors have cause to be concerned, Medco remains a solid long-term bet.

The first item is a tentative legal settlement under which average wholesale price will be reduced and then done away with. This price list is an anachronism that was once accurate and is now essentially an arbitrary calculation that for years has helped set consumer prices for prescription drugs.

For Medco and rivals Caremark Rx (NYSE: CMX  ) and Express Scripts (Nasdaq: ESRX  ) , the settlement will no doubt bring repercussions. However, once the average wholesale price is extinct, the effect -- a narrowing in the spread between manufacturer and consumer prices -- will be most dramatic for branded medicines. By contrast, the sweet spot of Medco's business is dispensing generic, not branded, medicines.

But a second development has raised doubts about Medco's generic side. Wal-Mart (NYSE: WMT  ) has begun to roll out a plan that offers shoppers a 30-day supply of 300 generics for the cut-rate co-pay of $4, below the price Medco and other pharmacy benefits managers charge for a number of generics.

Admittedly, Wal-Mart never should be taken lightly. However, even the world's retailing juggernaut might find that going head-to-head against Medco is not so wise. Thanks to Medco's automated dispensing facilities, its costs are low, so it's likely it can outcompete Wal-Mart on price. Also, many prescription drug users, particularly older consumers and those who suffer from chronic diseases, are likely to prefer home delivery through Medco's industry-leading mail-order pharmacy to filling prescriptions at Wal-Mart's gigantic superstores.

Medco's latest challenges may indeed buffet the company in the near term. However, its competitive advantages and the ongoing drive to contain prescription drug costs seem likely to keep Medco growing over the long term.

For related content, check out these articles:

Wal-Mart is a Motley Fool Inside Value selection. What is Wall Street overlooking now?Inside Valuegives subscribers the big names with the best prospects for good returns. A free trial gives you all the picks and how they're doing.

Fool contributor Brian Gorman does not own shares in any of the companies mentioned.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 516629, ~/Articles/ArticleHandler.aspx, 5/28/2016 6:30:07 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 9 hours ago Sponsored by:
DOW 17,873.22 44.93 0.25%
S&P 500 2,099.06 8.96 0.43%
NASD 4,933.51 31.74 0.65%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

4/2/2012 8:00 PM
MHS.DL $70.30 Down +0.00 +0.00%
Medco Health Solut… CAPS Rating: *****
ESRX $74.97 Up +0.26 +0.35%
Express Scripts CAPS Rating: *****
WMT $70.75 Down -0.10 -0.14%
Wal-Mart Stores CAPS Rating: ***